医療研究の倫理の進化:ヘルシンキ宣言 (1964年−2024年) の遡及的分析

Jovan Yi Jun Liau¹, Vishal G Shelat²

¹Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.

World journal of methodology

|September 3, 2025

まとめ

ヘルシンキ宣言 (DoH) は,人間を含む倫理的な医学研究を指針としています. 改訂は参加者の保護を強化し,研究ニーズと個人の権利と社会的利益のバランスをとります.

科学分野:

医学の倫理
研究倫理
人間対象の保護

背景:

ヘルシンキ宣言 (DoH) は,人間参加者を含む倫理的な医学研究のための基本文書です.
1964年に初めて設立されたDoHは,新たな倫理的課題と社会的価値に対処するために,複数の改訂を経て進化しました.
医者が害を避ける義務と介入の安全性と有効性を検証する必要性との間の固有の緊張を駆け巡らせます

研究の目的:

ヘルシンキ宣言の改正に反映された医療研究における倫理原則の進化を検証する.
研究参加者に対する保護措置の漸進的な強化を強調する.
科学的進歩,社会的利益,研究における個人の権利のバランスの変化を分析する.

主な方法:

ヘルシンキ宣言の歴史的繰り返しについて
保健省の異なるバージョンにおける主要な変化とテーマの発展の分析
報告された批判とDoHの実施に関連する課題の検討.

主要な成果:

患者の自律性と並行して配給の正義と福祉に重点を置いています
医療省は研究参加者の保護を徐々に強化してきました
その包括性にもかかわらず,情報に基づいた同意を得るなどの課題は残っています.

結論:

ヘルシンキ宣言は,ヒトの研究における倫理基準の改善に絶えず適応してきました.
参加者の保護は,DoH内の進化の一貫した焦点です.
この文書の継続的な関連性は,研究上の必要事項と倫理的な考慮のバランスをとるためのダイナミックなアプローチにあります.

キーワード:

ヘルシンキ宣言倫理について情報に基づく同意医学研究世界医学協会

さらに関連する動画

07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K

14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

関連する概念動画

02:20

Longitudinal Research

12.4K

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...

12.4K

01:19

Purpose of Health Records II

1.0K

Health records serve various essential purposes in the healthcare system. Here are some key purposes:

1.0K

01:18

Introduction To Survival Analysis

394

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...

394

01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

174

01:30

Primary Healthcare Services

1.5K

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

1.5K

01:11

Clinical Trials: Overview

3.4K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...